Originalkatalog | Verfügbarkeit prüfen

A prospective monitoring of fatal serious adverse events (SAEs) in a Dutch Colorectal Cancer Group (DCCG) phase III trial (CAIRO) in patients with advanced colorectal cancer

Mol, L., Koopman, M., Ottevanger, P.B., Punt, C.J.A.
Veröffentlicht in: Annals of Oncology ; volume 21, issue 2, page 415-418 ; ISSN 0923-7534;
2010

Originalkatalog | Verfügbarkeit prüfen

Effectiveness and toxicity of lenvatinib in refractory thyroid cancer: Dutch real-life data

Aydemirli, M D, Kapiteijn, E, Ferrier, K R M, Ottevanger, P B, Links, T P, van der Horst-Schrivers, A N A, Broekman, K E, Groenwold, R H H, Zwaveling, J
Veröffentlicht in: European Journal of Endocrinology ; volume 182, issue 2, page 131-138 ; ISSN 0804-4643 1479-683X;
2020

Originalkatalog | Verfügbarkeit prüfen

Neoadjuvant chemotherapy or primary debulking surgery in FIGO IIIC and IV patients:results from a survey study in the Netherlands

Timmermans, M., Sonke, G. S., van Driel, W. J., Lalisang, R. I., Ottevanger, P. B., de Kroon, C. D., Van de Vijver, K. K., van der Aa, M. A., Kruitwagen, R. F.
Veröffentlicht in: Timmermans , M , Sonke , G S , van Driel , W J , Lalisang , R I , Ottevanger , P B , de Kroon , C D , Van de Vijver , K K , van der Aa , M A & Kruitwagen , R F 2018 , ' Neoadjuvant chemotherapy or primary debulking surgery in FIGO IIIC and IV patients : results from a survey study in the Netherlands ' , European Journal of Obstetrics & Gynecology and Reproductive Biology , vol. 223 , pp. 98-102 . https://doi.org/10.1016/j.ejogrb.2018.02.029;
2018